LIMN Stock Analysis: Buy, Sell, or Hold?
LIMN - Liminatus Pharma, Inc. Class A Common Stock
$0.12
0.00 (-1.56%)
▼
5d:
-14.82%
30d:
-34.73%
90d:
-49.07%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jun 30, 2026
14d
Get Alerted When LIMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LIMN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LIMN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LIMN is currently trading at $0.12, which is considered oversold relative to its 30-day fair value range of $0.14 to $0.20.
Technical Outlook: Technically, LIMN is in a downtrend. The price is currently testing key support at $0.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LIMN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LIMN is in a downtrend. The price is currently testing key support at $0.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LIMN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.14 -
$0.20
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- CAUTION: 5-day price weakness (-14.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.14 -
$0.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.21
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Share & Embed Analysis
Last updated: June 15, 2026 5:04 PM ET
Data refreshes hourly during market hours. Next update: 6:04 PM
Data refreshes hourly during market hours. Next update: 6:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$275 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 58 HOLD |